Status:
COMPLETED
The Effect of Norepinephrine on Cardiac Output in Patients Undergoing Liver Transplant .
Lead Sponsor:
Cairo University
Conditions:
Liver Transplantation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Early administration of NE in liver transplant recipient might enhance cardiac output through an increase in cardiac preload .
Detailed Description
The derangement of circulatory blood volume in patients with liver cirrhosis makes intraoperative fluid management during liver transplant is challenging . Cirrhotic patients not only have large blood...
Eligibility Criteria
Inclusion
- All Adults (age \> 18 years) patients undergoing living donor liver transplant (LDLT) will be considered for inclusion in the study..
Exclusion
- Patients less than 18 years.
- Patients undergoing liver transplantation for acute liver failure .
- All Chronic Hypertensive patients on medication , whether controlled on not controlled
- Those with high risk of post transplant renal dysfunction (serum creatinine \>1.5 mg/dL at time of transplant)
Key Trial Info
Start Date :
December 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04376281
Start Date
December 15 2019
End Date
October 1 2021
Last Update
November 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
kasr El Ainy school of medicine
Cairo, Egypt, 11211